Entitlement offer Completed

PYC Therapeutics entitlement offer

A$146m raised

Announced 17 Feb 2025 · ASX: PYC · A$1.25 cash per share

Advisers

PYC Therapeutics

Issuer

Legal adviser

Lead managers

Joint lead manager
Underwriter
Custom Binders
Issuer
PYC Therapeutics
Structure
Accelerated non-renounceable entitlement offer
Completed
19 Feb 2025
Sector
Biotech and pharmaceuticals

Similar deals

All health care deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.